Canyon Resources (ASX:CAY) is approaching a critical stage as ownership discussions, funding uncertainty and development challenges converge around its Minim Martap bauxite project in Cameroon.
Atlas Arteria (ASX:ALX) released its half-year results for the six months ended 30 June 2026 on 27 August 2026, providing investors with an update on operational performance, cash generation and strategic priorities following a period of significant corporate change.
Commonwealth Bank (ASX:CBA) delivered a record FY26 result on 12 August 2026, highlighting continued strength across its bankingFranchisewhile also bringing valuation and credit quality considerations into focus.
Helia Group (ASX:HLI) delivered its 1H26 results on 11 August 2026, highlighting the company’s ability to maintain profitability and return capital despite a significant shift in its customer base.
Washington H. Soul Pattinson (ASX:SOL) continued its transformation into a broader investment group following the completion of its merger with Brickworks. The transaction reshaped one of Australia’s oldest listed investment companies, expanding its exposure across listed equities, real assets, private investments and credit opportunities.
McMillan Shakespeare (ASX:MMS) is set to release its FY26 full-year results on Friday, 28 August 2026, with investors looking for further clarity on earnings momentum, leasingDemandand the impact of changing electric vehicle policies.
Woolworths Group (ASX:WOW) delivered its FY26 full-year results on 26 August 2026, highlighting a recovery in earnings performance after a challenging period marked by cost-of-living pressures, competitive intensity and increased scrutiny across the supermarket sector.
Data#3 (ASX:DTL) delivered its FY26 full-year results on 24 August 2026, highlighting continued growth across its technology solutions business and increasing demand for digital transformation services.
Magellan Financial Group (ASX:MFG) delivered its FY26 results on 27 August 2026, marking the first financial update following the completion of its transformational merger with BarrenjoeyCapitalPartners.
Healius Limited (ASX:HLS) delivered a mixed FY26 result, highlighting meaningful progress in its underlying operational recovery while also reflecting the financial challenges associated with its broaderBusinessreset. The company reported a significant improvement in underlying profitability, supported by stronger pathology margins, cost reduction initiatives and …